http://blog.pharmexec.com/2008/10/24/health-20-internet-deja-vu/ The Business of Pharmaceuticals Wed, 10 Mar 2010 16:21:20 -0500 hourly 1 http://blog.pharmexec.com/2008/10/24/health-20-internet-deja-vu/comment-page-1/#comment-19567 Hope Leman Sun, 02 Nov 2008 10:15:27 +0000 http://blog.pharmexec.com/?p=364#comment-19567 Interesting take on the conference. Apropos of your comments, “If you or a loved one was just diagnosed with a serious disease, you will likely then turn to many websites to find answers and seek hope. So where do you place your trust?" I would say that the one service on display at Health 2.0 that really addressed such issues was Private Access: https://www.privateaccess.info/ It holds huge promise of offering hope and creating an environment of trust between patients and the research community. And if its services were offered on the home pages of each and every consumer health Web site (such as Healthline, RightHealth and Organized Wisdom) those who are in distress at a diagnosis and looking for hope and ways to take action could get involved in the clinical trials process in the earliest stages of their illness--which would be a huge a boon to researchers as well, as it is often the early stages of the disease process which hold the keys for improving treatments. It was Private Access that most impressed me at Health 2.0 and it will be fascinating to see which of the consumer Web sites are shrewd enough to approach it with offers to feature it on their sites. Consumers are proactive these days and enabling them to up for clinical trials in such a way that privacy is preserved would be a real service and selling point for these sites. Talk about traffic generating. Think of how often “clinical trial” is used as a search term. And what a boon it would be to pharma to open up pipelines of willing subjects. Win win for everyone. It is not that people don’t want to enroll in clinical trials. It is often that they do not know enough about the process. The consumer health sites could educate the public in this way by engaging consumers in the process via Private Access. That would be a public service, good business and the unique value you mention. Interesting take on the conference. Apropos of your comments, “If you or a loved one was just diagnosed with a serious disease, you will likely then turn to many websites to find answers and seek hope. So where do you place your trust?” I would say that the one service on display at Health 2.0 that really addressed such issues was Private Access:
https://www.privateaccess.info/
It holds huge promise of offering hope and creating an environment of trust between patients and the research community. And if its services were offered on the home pages of each and every consumer health Web site (such as Healthline, RightHealth and Organized Wisdom) those who are in distress at a diagnosis and looking for hope and ways to take action could get involved in the clinical trials process in the earliest stages of their illness–which would be a huge a boon to researchers as well, as it is often the early stages of the disease process which hold the keys for improving treatments.
It was Private Access that most impressed me at Health 2.0 and it will be fascinating to see which of the consumer Web sites are shrewd enough to approach it with offers to feature it on their sites. Consumers are proactive these days and enabling them to up for clinical trials in such a way that privacy is preserved would be a real service and selling point for these sites. Talk about traffic generating. Think of how often “clinical trial” is used as a search term. And what a boon it would be to pharma to open up pipelines of willing subjects. Win win for everyone. It is not that people don’t want to enroll in clinical trials. It is often that they do not know enough about the process. The consumer health sites could educate the public in this way by engaging consumers in the process via Private Access. That would be a public service, good business and the unique
value you mention.

]]> http://blog.pharmexec.com/2008/10/24/health-20-internet-deja-vu/comment-page-1/#comment-19455 Health 2.0 links for 10-27-08 | The eDrugSearch Blog Mon, 27 Oct 2008 14:05:42 +0000 http://blog.pharmexec.com/?p=364#comment-19455 [...] Health 2.0: Internet Déjà vu (PharmaExecBlog) [...] [...] Health 2.0: Internet Déjà vu (PharmaExecBlog) [...]

]]> http://blog.pharmexec.com/2008/10/24/health-20-internet-deja-vu/comment-page-1/#comment-19425 A Tentative Eye from Pharma Sun, 26 Oct 2008 17:56:35 +0000 http://blog.pharmexec.com/?p=364#comment-19425 [...] space.  In contrast to the consumer-focused search and portal sites that I commented about in my previous post who are still competing to earn the trust of Internet health seekers, Sermo appears to have won the [...] [...] space.  In contrast to the consumer-focused search and portal sites that I commented about in my previous post who are still competing to earn the trust of Internet health seekers, Sermo appears to have won the [...]

]]> http://blog.pharmexec.com/2008/10/24/health-20-internet-deja-vu/comment-page-1/#comment-19028 ICMCC Newspage » Blog Archive » Health 2.0: Internet Déjà vu Fri, 24 Oct 2008 18:08:56 +0000 http://blog.pharmexec.com/?p=364#comment-19028 [...] of some of the new companies out there, it all starts to sound the same after a while.” Article Andy Levitt, PharmExecBlog, 24 October [...] [...] of some of the new companies out there, it all starts to sound the same after a while.” Article Andy Levitt, PharmExecBlog, 24 October [...]

]]>